The lack of testing and testing capacity in the US is deeply alarming. They’ve only run 500 tests so far and criteria still require the patient to have recently traveled from Hubei! By comparison South Korea is running thousands of tests per day, which is why it is picking up so many cases. Absolutely unforgivable complacency and lack of transparency from CDC. There is almost certainly community spreading in the US t…
Probably unlikely, given the understandable emphasis in the medical community on gold-standard diagnostic methods. But if one of these companies can collaborate with the CDC to get their hands on a large number of patient samples for validation, the FDA for quick approval, and a reliable manufacturing partner for scale-up, the possibility exists.
(Edit: spelling and added required collaborators to the list)